You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumour-agnostic

Showing 1 - 25 of 1,769
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study

Not yet recruiting
  • CNS Lymphoma
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Apr 12, 2023

    The Diverticulitis Study

    Recruiting
    • Colonic Diverticulitis
    • +2 more
      • Herlev, Capital Region Of Denmark, Denmark
      • +4 more
      Sep 1, 2023

      Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

      Recruiting
      • Advanced Solid Tumor
      • +13 more
      • Duarte, California
      • +3 more
      Oct 25, 2022

      Malignancy, Malignant Tumor, Lymphoproliferative Disorders Trial in United Kingdom (Atezolizumab)

      Not yet recruiting
      • Malignancy
      • +8 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

      Recruiting
      • Cancer
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      Mar 3, 2022

      Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

      Recruiting
      • Solid Tumor
      • Haematological Malignancy
      • Belfast, United Kingdom
      • +24 more
      Jan 31, 2023

      Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

      Recruiting
      • Solid Tumor
      • +11 more
      • Belfast, United Kingdom
      • +16 more
      Mar 2, 2023

      Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

      Not yet recruiting
      • Unspecified Adult Solid Tumor, Protocol Specific
      • (no location specified)
      Jun 23, 2022

      Solid Tumor Trial in Singapore (CURATE.AI, Capecitabine, XELOX)

      Recruiting
      • Solid Tumor
      • CURATE.AI
      • +4 more
      • Singapore, Singapore
      • +1 more
      Dec 14, 2021

      Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 28, 2023

      Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Metastasis to Liver, Colorectal Cancer Trial (Double low dose CT, Standard dose CT)

      Not yet recruiting
      • Metastasis to Liver
      • Colorectal Cancer
      • Double low dose CT
      • Standard dose CT
      • (no location specified)
      Mar 30, 2023

      Anal Cancer Trial in Gothenburg (Biopsies)

      Not yet recruiting
      • Anal Cancer
      • Biopsies
      • Gothenburg, Sweden
        Dept. of Surgery, Sahlgrenska University Hospital/Ostra
      Jul 3, 2023

      Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH), Non-Langerhans-Cell Histiocytosis Trial in Cleveland (Genetic

      Recruiting
      • Castleman's Disease (CD)
      • +2 more
      • Genetic testing
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jun 21, 2022

      Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

      Not yet recruiting
      • Glioblastoma Multiforme, Adult
      • Recurrent Glioblastoma
      • Pitavastatin calcium
      • Rotterdam, Netherlands
        Erasmus MC
      Aug 3, 2023

      Cancer Trial in Milwaukee (Targeted agent, Standard of care agent)

      Not yet recruiting
      • Cancer
      • Targeted agent
      • Standard of care agent
      • Milwaukee, Wisconsin
        Froedtert Hospital & the Medical College of Wisconsin
      Jan 8, 2023

      DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using

      Recruiting
      • Ovarian Neoplasms
      • +8 more
        • Montreal, Quebec, Canada
        • +1 more
        Oct 14, 2021

        less Image Guidance Using Intrafraction Kolovoltage X-ray

        Recruiting
        • Lung Cancer
        • +2 more
        • Markerless Tumour Tracking
        • Saint Leonards, New South Wales, Australia
          Royal North Shore Hospital
        Oct 25, 2022

        Breast Cancer, Breast Cancer Invasive Trial in Groningen (Fluorescence guided detection of tumor positive margins.)

        Not yet recruiting
        • Breast Cancer
        • Breast Cancer Invasive
        • Fluorescence guided detection of tumor positive margins.
        • Groningen, Netherlands
        • +1 more
        Jul 10, 2023

        Metastatic Solid Tumor Trial in Odense C (genomic profiling)

        Recruiting
        • Metastatic Solid Tumor
        • genomic profiling
        • Odense C, Denmark
          Odense Universitets Hospital dept of oncology
        May 19, 2022

        Prospective Tissue Collection Research Protocol

        Recruiting
        • Solid Tumor
        • Tumour tissue collection
        • New York, New York
        • +17 more
        Jan 16, 2023

        Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

        Recruiting
        • Solid Tumors
        • Daphne, Alabama
        • +156 more
        Jan 13, 2023

        Glioblastoma Trial in Rotterdam (Extended MRI)

        Recruiting
        • Glioblastoma
        • Extended MRI
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus Medical Center
        Jul 24, 2023

        Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

        Not yet recruiting
        • Clear Cell Renal Cell Carcinoma Metastatic
        • +4 more
        • (no location specified)
        Jan 13, 2023